BillionToOne (BLLN) vs RadNet (RDNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
RadNet is the larger company by market cap ($5.31 billion vs $4.50 billion), about 1.2 times the size, while BillionToOne is growing revenue faster (+100.0% vs +11.5%). On valuation, BillionToOne trades at a lower forward P/E (64.2x vs 76.2x for RadNet). BillionToOne converts more of its revenue into profit, with a net margin of 2.4% versus -0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLLN | RDNT |
|---|---|---|
| Share price | $95.27 | $67.53 |
| Market cap | $4.50B | $5.31B |
| 1-day change | -0.50% | -1.58% |
| YTD return | +17.00% | -3.84% |
| 1-year return | — | -11.94% |
| 5-year return | — | +138.39% |
| P/E ratio (TTM) | 151.22 | — |
| Forward P/E | 64.15 | 76.16 |
| EPS (TTM) | $0.63 | $-0.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $305.11M | $2.04B |
| Revenue growth (YoY) | +99.97% | +11.51% |
| Net income (latest FY) | $7.45M | $-18.65M |
| Gross margin | 68.32% | — |
| Operating margin | 5.25% | 3.04% |
| Net margin | 2.44% | -0.91% |
| 52-week high | $150.44 | $85.84 |
| 52-week low | $61.96 | $50.82 |
| Distance from 52-week high | -36.67% | -21.34% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +35.40% | +40.14% |
| Average volume | 696.43K | 711.40K |
| Shares outstanding | 42.64M | 78.70M |
| Employees | 713 | 11,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BillionToOne grew revenue faster in its latest fiscal year (+99.97% vs +11.51%).
About BillionToOne
BLLN stock →BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
Health Care · Medical Specialities · 713 employees
About RadNet
RDNT stock →RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health.
Health Care · Medical Specialities · 11,000 employees
BLLN vs RDNT FAQ
Which is bigger, BillionToOne or RadNet?
RadNet (RDNT) is larger, with a market capitalization of $5.31B compared with $4.50B for BillionToOne (BLLN).
Are BillionToOne and RadNet in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.